Reply to Distinguishing between CISNET model results versus CISNET models. Read more about Reply to Distinguishing between CISNET model results versus CISNET models.
Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials. Read more about Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.
Reply to Opportunity cost of annual screening mammography. Read more about Reply to Opportunity cost of annual screening mammography.
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. Read more about Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Travel distance and stereotactic body radiotherapy for localized prostate cancer. Read more about Travel distance and stereotactic body radiotherapy for localized prostate cancer.
Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns. Read more about Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial. Read more about Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report. Read more about Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704. Read more about Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases. Read more about Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
